REGISTERED NUMBER: 06725408 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2025

FOR

MEDICINE AND SONS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

R Daniels

G R Towlerton

REGISTERED OFFICE:

C/O TC Thompson Taraz Rand

Suite 20, New Cambridge House

Bassingbourn Road

Litlington

Cambridgeshire

SG8 0SS

REGISTERED NUMBER:

06725408 (England and Wales)

ACCOUNTANTS:

TC Group

1st Floor

5-7 Portugal Place

Cambridge

Cambridgeshire

CB5 8AF

FIXED ASSETS

Intangible assets

5

-

-

Tangible assets

6

17,320

23,093

Investments

7

-

-

17,320

23,093

CURRENT ASSETS

Debtors

8

541,555

619,959

Cash and cash equivalents

25,896

95,212

567,451

715,171

CREDITORS

Amounts falling due within one year

9

(27,824

)

(29,358

)

NET CURRENT ASSETS

539,627

685,813

TOTAL ASSETS LESS CURRENT LIABILITIES

556,947

708,906

PROVISIONS FOR LIABILITIES

10

(2,871

)

(3,994

)

NET ASSETS

554,076

704,912

CAPITAL AND RESERVES

Called up share capital

11

2

2

Retained earnings

554,074

704,910

SHAREHOLDERS' FUNDS

554,076

704,912

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 October 2026 and were signed on its behalf by:

G R Towlerton - Director

1.	STATUTORY INFORMATION

Medicine and Sons Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is derived from general medical practice activities and measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business, is being amortised evenly over its estimated useful life.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

25% on cost, 25% on reducing balance and 20% on cost

Financial instruments

Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - 2 ).

5.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 November 2024

and 31 October 2025

252,000

AMORTISATION

At 1 November 2024

and 31 October 2025

252,000

NET BOOK VALUE

At 31 October 2025

-

At 31 October 2024

-

6.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 November 2024

and 31 October 2025

72,882

DEPRECIATION

At 1 November 2024

49,789

Charge for year

5,773

At 31 October 2025

55,562

NET BOOK VALUE

At 31 October 2025

17,320

At 31 October 2024

23,093

7.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 November 2024

and 31 October 2025

60,000

PROVISIONS

At 1 November 2024

and 31 October 2025

60,000

NET BOOK VALUE

At 31 October 2025

-

At 31 October 2024

-

8.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

8,899

8,900

Other debtors

532,656

611,059

541,555

619,959

9.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Taxation and social security

25,130

23,175

Other creditors

2,694

6,183

27,824

29,358

10.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

2,871

3,994

Deferred

tax

£

Balance at 1 November 2024

3,994

Provided during year

(1,123

)

Balance at 31 October 2025

2,871

11.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

2

Ordinary

£1

2

2

12.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 October 2025 and 31 October 2024:

2025

2024

£

£

R Daniels

Balance outstanding at start of year

35,613

(2,814

)

Amounts advanced

121,600

49,909

Amounts repaid

(147,957

)

(11,482

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

9,256

35,613

G R Towlerton

Balance outstanding at start of year

35,613

-

Amounts advanced

121,600

49,909

Amounts repaid

(147,957

)

(14,296

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

9,256

35,613

13.	RELATED PARTY DISCLOSURES

At the balance sheet date an amount of £514,143 (2024: £539,834) was due from a company under common control and is disclosed within other debtors.